GSK Pharma Fact Sheet, GSK Pharma Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK Pharma Fact Sheet    (GLXO)


Watch: Predict Stock's Next Move Using Volumes


Here is the latest financial fact sheet of GSK Pharma. For more details, see the GSK Pharma quarterly results and GSK Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

GSK PHARMA Price History

Price Rs 1,681.7
Mkt Cap Rs m 284,890
Vol '000 12.8
P/E X 79.5
P/CF X 65.1
EPS (TTM) Rs 21.1
% ch % 4.5
No. of shares m 169.41
% ch week % 8.9
% ch 1-mth % 11.3
% ch 12-mth % 14.5
52 week H/L Rs 1,805.0/1,379.0
(As on Jul 23, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

GSK PHARMA Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
GSK PHARMA EQUITY SHARE DATA
High Rs3,8382,7603,5951,7451,805 
Low Rs2,6002,0401,2531,0461,155 
Sales per share (Unadj.) Rs332.6336.2184.6190.3188.8 
Earnings per share (Unadj.) Rs39.841.426.35.521.1 
Diluted earnings per shareRs19.920.726.35.521.1 
Cash flow per share (Unadj.) Rs42.945.929.210.425.8 
Dividends per share (Unadj.) Rs30.0035.0020.0040.0030.00 
Adj. dividends per shareRs15.0017.5020.0040.0030.00 
Dividend yield (eoy) %0.91.50.82.92.0 
Book value per share (Unadj.) Rs236.9242.9126.3107.588.5 
Adj. book value per shareRs118.5121.4126.3107.588.5 
Shares outstanding (eoy) m84.7084.70169.41169.41169.41 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x9.77.113.17.37.8 
Avg P/E ratio x81.058.092.2253.770.0 
P/CF ratio (eoy) x75.152.383.1134.457.3 
Price / Book Value ratio x13.69.919.213.016.7 
Dividend payout %75.484.576.1727.0141.9 
Avg Mkt Cap Rs m272,659203,287410,644236,440250,695 
No. of employees `000NANANANANA 
Total wages/salary Rs m4,8305,2345,3726,2866,147 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
GSK PHARMA INCOME DATA
Net Sales Rs m28,17028,47331,28132,24431,989 
Other income Rs m7315451,0237901,106 
Total revenues Rs m28,90029,01832,30433,03433,094 
Gross profit Rs m4,6475,2366,2953,1585,227 
Depreciation Rs m263380486827793 
Interest Rs m3266335 
Profit before tax Rs m5,1125,4006,8273,0585,505 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m1,7441,8922,3732,1251,924 
Profit after tax Rs m3,3683,5074,4549323,581 
Gross profit margin %16.518.420.19.816.3 
Effective tax rate %34.135.034.869.534.9 
Net profit margin %12.012.314.22.911.2 
GSK PHARMA BALANCE SHEET DATA
Current assets Rs m18,35135,35533,59217,74922,027 
Current liabilities Rs m8,81129,49028,04110,22013,325 
Net working cap to sales %33.920.617.723.427.2 
Current ratio x2.11.21.21.71.7 
Inventory Days Days5053663514247 
Debtors Days Days221914113246 
Net fixed assets Rs m47,52541,03344,45112,4798,076 
Share capital Rs m8478471,6941,6941,694 
"Free" reserves Rs m19,22219,72619,70416,51213,297 
Net worth Rs m20,06920,57321,39818,20614,991 
Long term debt Rs m106200 
Total assets Rs m65,87676,38878,04330,22730,102 
Interest coverage x2,045.72,858.01,233.349.3156.9 
Debt to equity ratio x00000 
Sales to assets ratio x0.40.40.41.11.1 
Return on assets %5.14.65.73.312.0 
Return on equity %16.817.020.85.123.9 
Return on capital %25.526.231.917.137.0 
Exports to sales %00000 
Imports to sales %25.526.122.727.10.9 
Exports (fob) Rs m00000 
Imports (cif) Rs m7,1937,4297,0918,750276 
Fx inflow Rs m528564534276278 
Fx outflow Rs m7,1937,4297,0918,750276 
Net fx Rs m-6,665-6,865-6,557-8,4742 
GSK PHARMA CASH FLOW
From Operations Rs m 2,344 4,728 4,095 4,905 5,779 
From Investments Rs m 3,006 -1,042 -1,535 -568 4,186 
From Financial Activity Rs m -5,108 -3,066 -3,584 -4,276 -6,961 
Net Cashflow Rs m 242 620 -1,023 60 3,004 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Indian Promoters 0.0%
Foreign collaborators 75.0%
Indian inst/Mut Fund 12.5%
FIIs 1.6%
ADR/GDR 0.0%
Free float 25.0%
Shareholders 120,476
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Dr Annie Besant Road, Worli, Mumbai - 400030
E-MAIL askus@gsk.com WEB www.gsk-india.com
TEL 022-24959595 FAX 022-24959494
SECTOR PHARMACEUTICALS GROUP Glaxo (F) Group
TR AGENT K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.), Karvy Selenium Tower B Plot 31-32, Gachibowli Financial District, Nanakramguda
AUDITOR Price Waterhouse & Co.
CHM: D. S. Parekh COMP SEC: A. A. Nadkarni (GM & Admin) YEAR OF INC: 1924 BSE CODE: 500660 FV (Rs): 10 DIV YIELD (%): 1.8

Read: GSK PHARMA 2018-19 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   DHANVANTRI JEEV  BLISS GVS PHARMA  VIVANZA BIOSCIENCES  GLENMARK PHARMA  BHARAT PARENTALS  

Compare GSK PHARMA With:   DHANVANTRI JEEV  BLISS GVS PHARMA  VIVANZA BIOSCIENCES  GLENMARK PHARMA  BHARAT PARENTALS  




Today's Market

Sensex Ends 139 Points Higher; ICICI Bank, Wipro and ITC Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Views on news

GSK PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 124.4% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, GSK PHARMA has posted a net profit of Rs 2 bn (up 124.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.2% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (2QFY21); Net Profit Down 84.8% (Quarterly Result Update)

Oct 30, 2020 | Updated on Oct 30, 2020

For the quarter ended September 2020, GSK PHARMA has posted a net profit of Rs 765 m (down 84.8% YoY). Sales on the other hand came in at Rs 9 bn (down 0.3% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

Why Did Pharma Stocks Surge? (Views On News)

Jul 17, 2021

A look into the factors contributing to the rally in pharma stocks.

Bajaj Healthcare Rallies 11% on DRDO Nod to Manufacture Oral Covid Drug (Views On News)

Jul 8, 2021

Bajaj Healthcare has more than doubled investors' wealth in the year 2021 so far. The counter has delivered over 240% return in the last one year.

Aurobindo Pharma Rallies on Sale of Injectables Unit to Subsidiary (Views On News)

Jul 2, 2021

Here's why the company sold its business unit to Eugia Pharma Specialities.

More Views on News

Most Popular

A 25 Bagger Indian Stock at the Centre of the Global Semiconductor Chip Shortage (Profit Hunter)

Jul 13, 2021

One technology company in India is grossly underrated despite its dominant role in semiconductor chip designing.

RBI Opens a New Market for Investors (Fast Profits Daily)

Jul 16, 2021

You now have a new way to create wealth. Grab it with both hands.

OPEC is Dying! RIP OPEC (Fast Profits Daily)

Jul 13, 2021

Why the global oil cartel is unravelling and how India stands to gain.

Top 4 Companies that Are Strong Monopolies (Views On News)

Jul 10, 2021

A close look at the top 4 companies with a dominant position in their industry.

A Better Way than the Zomato IPO to Play the Food Delivery Megatrend (Profit Hunter)

Jul 14, 2021

A unique backdoor way of making big profits from smallcap companies.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GSK PHARMA

GSK PHARMA 8-QTR ANALYSIS

COMPARE GSK PHARMA WITH

MARKET STATS